These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15081773)

  • 1. Modelling skin permeability in risk assessment--the future.
    Fitzpatrick D; Corish J; Hayes B
    Chemosphere; 2004 Jun; 55(10):1309-14. PubMed ID: 15081773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple dermal absorption model: derivation and application.
    ten Berge W
    Chemosphere; 2009 Jun; 75(11):1440-5. PubMed ID: 19304310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes.
    Buist HE; van Burgsteden JA; Freidig AP; Maas WJ; van de Sandt JJ
    Regul Toxicol Pharmacol; 2010; 57(2-3):200-9. PubMed ID: 20178823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New tools and approaches for predicting skin permeability.
    Degim IT
    Drug Discov Today; 2006 Jun; 11(11-12):517-23. PubMed ID: 16713903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical models of skin permeability: an overview.
    Mitragotri S; Anissimov YG; Bunge AL; Frasch HF; Guy RH; Hadgraft J; Kasting GB; Lane ME; Roberts MS
    Int J Pharm; 2011 Oct; 418(1):115-29. PubMed ID: 21356301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the applicability of (Q)SARs for percutaneous penetration in regulatory risk assessment.
    Bouwman T; Cronin MT; Bessems JG; van de Sandt JJ
    Hum Exp Toxicol; 2008 Apr; 27(4):269-76. PubMed ID: 18684796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomonitoring as a tool in the human health risk characterization of dermal exposure.
    Boogaard PJ
    Hum Exp Toxicol; 2008 Apr; 27(4):297-305. PubMed ID: 18684800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the effect of mixture components on permeation through skin.
    Ghafourian T; Samaras EG; Brooks JD; Riviere JE
    Int J Pharm; 2010 Oct; 398(1-2):28-32. PubMed ID: 20643197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration: summary and evaluation of USEPA's mandated testing.
    Fasano WJ; McDougal JN
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):181-94. PubMed ID: 18501488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilayered dermal subcompartments for modeling chemical absorption.
    Bookout RL; McDaniel CR; Quinn DW; McDougal JN
    SAR QSAR Environ Res; 1996; 5(3):133-50. PubMed ID: 9114511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experimentally based approach for predicting skin permeability of chemicals and drugs using a membrane-coated fiber array.
    Xia XR; Baynes RE; Monteiro-Riviere NA; Riviere JE
    Toxicol Appl Pharmacol; 2007 Jun; 221(3):320-8. PubMed ID: 17493652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopartitioning micellar chromatography to predict skin permeability.
    Martínez-Pla JJ; Martín-Biosca Y; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    Biomed Chromatogr; 2003 Dec; 17(8):530-7. PubMed ID: 14648611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of indices proposed as criteria for assigning skin notation.
    Lavoué J; Milon A; Droz PO
    Ann Occup Hyg; 2008 Nov; 52(8):747-56. PubMed ID: 18687973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MI-QSAR models for prediction of corneal permeability of organic compounds.
    Chen C; Yang J
    Acta Pharmacol Sin; 2006 Feb; 27(2):193-204. PubMed ID: 16412269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting MDCK cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.
    Chen LL; Yao J; Yang JB; Yang J
    Acta Pharmacol Sin; 2005 Nov; 26(11):1322-33. PubMed ID: 16225754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of appropriate training and validation set chemicals for modelling dermal permeability by U-optimal design.
    Xu G; Hughes-Oliver JM; Brooks JD; Yeatts JL; Baynes RE
    SAR QSAR Environ Res; 2013; 24(2):135-56. PubMed ID: 23157374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From dermal exposure to internal dose.
    Van de Sandt JJ; Dellarco M; Van Hemmen JJ
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S38-47. PubMed ID: 17440485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a quantitative structure-permeability relationship (QSPR) for the transdermal delivery of NSAIDs.
    Liou YB; Ho HO; Yang CJ; Lin YK; Sheu MT
    J Control Release; 2009 Sep; 138(3):260-7. PubMed ID: 19467276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationship (QSAR) modeling of human blood: air partitioning with proper statistical methods and validation.
    Basak SC; Mills D; Hawkins DM; Kraker JJ
    Chem Biodivers; 2009 Apr; 6(4):487-502. PubMed ID: 19353545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.